REQUEST A DEMO
Total
USD $0.00
Search more companies

Alifarmed OOO (Альфармед ООО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Alifarmed OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Alifarmed OOO (Альфармед ООО) is a company in Russia, with a head office in Moscow. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on December 12, 2019. There was a net sales revenue increase of 201.86% reported in Alifarmed OOO (Альфармед ООО)’s latest financial highlights for 2024. There was a total growth of 113.57% in Alifarmed OOO (Альфармед ООО)’s total assets over the same period.

Headquarters
Voroncovskaya, 35B, 2, 28/3/2
Moscow; Moscow; Postal Code: 109147

Contact Details: Purchase the Alifarmed OOO (Альфармед ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the Alifarmed OOO (Альфармед ООО) report to view the information.
Incorporation Date:
December 12, 2019
Company Performance
Financial values in the chart are available after Alifarmed OOO (Альфармед ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
201.86%
Total operating revenue
201.86%
Operating profit (EBIT)
-60.01%
Net Profit (Loss) for the Period
N/A
Total Assets
113.57%
Total Equity
9.5%
Operating Profit Margin (ROS)
7.19%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.29%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?